Gacovino, Lake & Associates, P.C.
270 W Main St, Sayville, NY 11782, Sayville, NY 11782
About Gacovino, Lake & Associates, P.C.
Gacovino, Lake & Associates, P.C. is a personal injury law firm established in 1993 by Steven Gacovino and Edward Lake. The firm represents clients in New York and across the country. Its practice areas include vehicle accidents, medical malpractice, dangerous drugs, and defective medical devices. The firm has five attorneys and has recovered hundreds of millions of dollars for clients. Edward Lake helped develop one of the nation's largest mass tort practices.
Our Attorneys
Notable Case Results
Case results are sourced directly from attorney websites by Injuria.ai's data infrastructure, which actively monitors 22,000+ personal injury law firms. They are not results obtained by ThatCarHitMe.com. Every case is unique and must be evaluated on its own facts. Prior results do not guarantee a similar outcome. The results shown are not necessarily representative of all results obtained by these firms.
$402M
Dangerous Drugs
Settlement by Bayer AG for thousands of lawsuits linking their oral contraceptives Yasmin and Yaz to blood clots.
$389M
Whistleblower
Whistleblower lawsuit against kidney dialysis company DaVita Healthcare Partners for illegal kickbacks to doctors in exchange for patient referrals.
$181M
Pharmaceutical Fraud
Settlement where Johnson & Johnson agreed to pay 36 U.S. states and the District of Columbia for improperly marketing its Risperdal antipsychotic drug for unapproved uses.
$130M
Medical Malpractice
Settlement for a Long Island family whose daughter developed cerebral palsy due to lack of oxygen during delivery at St. Charles Hospital and Rehabilitation Center, caused by alleged medical negligence.
$78M
Medical Malpractice
Award to a mother and daughter in Philadelphia for medical malpractice involving the daughter’s avoidable birth defect (spastic quadriplegic cerebral palsy) due to care received at Pottstown Memorial Medical Center.
$74M
Antitrust Violation
Settlement where Bayer Corporation agreed to pay for allegedly violating antitrust laws by participating in 'pay-for-delay' activities to restrict competition against its antibiotic drug Cipro.